FREDERICK, Md.--(BUSINESS WIRE)--BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable, drug-free anti-inflammatory devices, today announced a major upgrade to its ActiPatch Therapy® product line. The upgrade consists of a new methodology for attaching the Company’s patented technology to the human body.
